Madrigal

Stock Market

Madrigal Stock Triples After Liver Disease Drug Succeeds in Trial

[ad_1] (Bloomberg) — Madrigal Pharmaceuticals Inc. shares surged 268%, adding about $2.9 billion to its market value, after a late-stage…

Read More »
Stock Market

Viking Therapeutics’ stock rallies after Madrigal shares positive data about its liver drug

[ad_1] Shares of Viking Therapeutics Inc. VKTX, +4.42% jumped 55% in premarket trading on Monday after a company that is…

Read More »
Back to top button
Close